TEST BANK FOR RAUS RESPIRATORY CARE
n7 n7 n7 n7 n7
PHARMACOLOGY11th EDITION BY GARDENHIRE/ALL
n7 n
7 n7 n7 n7
CHAPTERS S 1-23
n7 n7 n7
,CH 01: Introduction to Respiratory Care Pharmacology
n7 n7 n7 n7 n7 n7 n7
Gardenhire: Rau’s Respiratory Care Pharmacology, 11th
n7 n7 n7 n7 n7 n7
Edition
n7
MULTIPLE RESPONSE n7
1. The listing of a drug and the amount of drug are found in which part of a prescription?
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
a. Superscription
b. Inscription
c. Subscription
d. Transcription (signature) n7
PRECISE ANSWER:-B n7
Reasoning :->>>The superscription directs the registered pharmacist to take the drug listed and
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
preparethe drug; the inscription lists the name and quantity of the drug being prescribed; the
n7 7
n n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
subscriptionprovides directions to the registered pharmacist for preparing the drug; and the transcription,
n7 7
n n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
or signature, is the information the registered pharmacist writes on the label as instructions to the
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
patient.
n7
REFERENCE: n 7 p. 7 n7
2. If generic substitution is permitted on a prescription:
n7 n7 n7 n7 n7 n7 n7
a. drug from only one manufacturer must be given.
n7 n7 n7 n7 n7 n7 n7
b. drug formulation may be changed by the registered pharmacist.
n7 n7 n7 n7 n7 n7 n7 n7
c. any manufactured brand of the drug listed may be given.
n7 n7 n7 n7 n7 n7 n7 n7 n7
d. drug strength may be changed by the registered pharmacist.
n7 n7 n7 n7 n7 n7 n7 n7
PRECISE ANSWER:-C n7
Reasoning :->>>A generic substitution allows any brand of a drug to be given, but the registered
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
pharmacist may not change a drug formulation without specific permission from the prescribing
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
physician. A physician can indicate to the registered pharmacist that generic substitution is permitted in
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
the filling of the prescription. In such a case, the registered pharmacist may provide any manufacturer’s
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
version of the prescribed drug, rather than a specific brand. However, the registered pharmacist may not
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
change thestrength of a drug without specific permission from the prescribing physician.
n7 n7 7
n n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
REFERENCE: n 7 p. 8 n7
3. The study of drug, including their origin, properties, and interactions with living organisms, is known as
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
a. pharmacogenetics.
b. pharmacology.
c. therapeutics.
d. toxicology.
PRECISE ANSWER:-B n7
Reasoning:->>>Pharmacogenetics is the study of the interrelationship of genetic differences and drug n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
effects. Pharmacology is the study of drug (chemicals), including their origin, properties, and
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
interactionswith living organisms.
n7 7
n n7 n7
Therapeutics is the art of treating illness with drug. Toxicology is the study of toxic substances and
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
theirpharmacologic actions, including antidotes and poison control.
n7 n7 n7 n7 n7 n7 n7 n7
REFERENCE: n 7 p. 3 n7
4. The brand name given to a drug by a particular manufacturer is known as the drug’s
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
a. chemical name. n7
b. generic name. c.official name. d.trade name.
n7 n7 n7 n7 n7
PRECISE ANSWER:-D n7
,Reasoning:->>>The chemical name indicates the drug’s chemical structure. The generic name is assignedby
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 7
n
the United States
n7 n7 n7
, Adopted Name Council and is usually based loosely on the drug’s chemical structure. The official name isthe
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 7
n
name given to the generic name once a drug becomes fully approved for general use and is admitted to
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
the United States Pharmacopeia–National Formulary. The trade name is the brand, or proprietary, name
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
given by a particular manufacturer. For example, the generic drug albuterol is currently marketed by
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
Schering-Plough as Proventil® and by GlaxoSmithKline as Ventolin®.
n7 7
n n7 n7
n7
n7 n7 n7 n7
REFERENCE: n 7 p. 5 n7
5. To find official information about drug (according to the FDA), you need to go to the
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
a. Physician’s Desk Referenceerence (PDR). n7 n7 n7
b. Basic & Clinical Pharmacology. n7 n7 n7
c. United States Pharmacopeia–National Formulary (USP-NF).
n7 n7 n7 n7
d. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. n7 n7 n7 n7 n7 n7 n7
PRECISE ANSWER:-C n7
Reasoning:->>>Because the PDR is prepared by drug manufacturers themselves, it may be lacking in n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
objectivity. Basic & Clinical Pharmacology covers only general pharmacologic principles and drug
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
classes. Goodman & Gilman’s The Pharmacological Basis of Therapeutics covers only general
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
pharmacologicprinciples and drug classes. The USP-NF is a book of standards containing information
n7 7
n n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
about drugs, dietary supplements, and medical devices. The U.S. Food and Drug Administration
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
(FDA)considers this book the official standard for drug marketed in the United States.
n7 7
n n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
REFERENCE: n 7 p. 5 n7
6. Drug may be obtained from which of the following sources?
n7 n7 n7 n7 n7 n7 n7 n7 n7
a. Plants
b. Animals
c. Minerals
d. Plants, animals, and minerals n7 n7 n7
PRECISE ANSWER:-D n7
Reasoning:->>>Drug may be obtained from plants (e.g., digitalis), animals (e.g., insulin), and minerals(e.g.,
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 7
n
magnesium sulfate).
n7 n7
REFERENCE: n 7 p. 5 n7
7. The branch of the U.S. government responsible for the process of approving drug for clinical use is the
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
a. USAN Council. n7
b. FDA.
c. USP-NF.
d. PDR.
PRECISE ANSWER:-B n7
Reasoning:->>>The United States Adopted Name (USAN) Council is responsible for assigning a generic n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
name to a chemical that appears to have therapeutic use. The U.S. Food and Drug Administration
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
(FDA) is responsible for the process of approving drug for clinical use. The process by which a
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
chemical movesfrom the status of a promising potential drug to one fully approved by the FDA for
n7 n7 7
n n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
general clinical use is,on average, long, costly, and complex. Cost estimates vary, but in the 1980s it
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
took an average of 13 to 15 yearsfrom chemical synthesis to marketing approval by the FDA, with a cost
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
of $350 million in the United States.
n7 n7 n7 n7 n7 n7 n7
The USP-NF is a book
n7 n7 n7 n7
of standards for drugs, dietary supplements, and medical devices. The PDR is a source of druginformation
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 7
n
prepared by drug manufacturers.
n7 n7 n7 n7
REFERENCE: n 7 p. 4 n7
n7 n7 n7 n7 n7
PHARMACOLOGY11th EDITION BY GARDENHIRE/ALL
n7 n
7 n7 n7 n7
CHAPTERS S 1-23
n7 n7 n7
,CH 01: Introduction to Respiratory Care Pharmacology
n7 n7 n7 n7 n7 n7 n7
Gardenhire: Rau’s Respiratory Care Pharmacology, 11th
n7 n7 n7 n7 n7 n7
Edition
n7
MULTIPLE RESPONSE n7
1. The listing of a drug and the amount of drug are found in which part of a prescription?
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
a. Superscription
b. Inscription
c. Subscription
d. Transcription (signature) n7
PRECISE ANSWER:-B n7
Reasoning :->>>The superscription directs the registered pharmacist to take the drug listed and
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
preparethe drug; the inscription lists the name and quantity of the drug being prescribed; the
n7 7
n n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
subscriptionprovides directions to the registered pharmacist for preparing the drug; and the transcription,
n7 7
n n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
or signature, is the information the registered pharmacist writes on the label as instructions to the
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
patient.
n7
REFERENCE: n 7 p. 7 n7
2. If generic substitution is permitted on a prescription:
n7 n7 n7 n7 n7 n7 n7
a. drug from only one manufacturer must be given.
n7 n7 n7 n7 n7 n7 n7
b. drug formulation may be changed by the registered pharmacist.
n7 n7 n7 n7 n7 n7 n7 n7
c. any manufactured brand of the drug listed may be given.
n7 n7 n7 n7 n7 n7 n7 n7 n7
d. drug strength may be changed by the registered pharmacist.
n7 n7 n7 n7 n7 n7 n7 n7
PRECISE ANSWER:-C n7
Reasoning :->>>A generic substitution allows any brand of a drug to be given, but the registered
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
pharmacist may not change a drug formulation without specific permission from the prescribing
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
physician. A physician can indicate to the registered pharmacist that generic substitution is permitted in
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
the filling of the prescription. In such a case, the registered pharmacist may provide any manufacturer’s
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
version of the prescribed drug, rather than a specific brand. However, the registered pharmacist may not
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
change thestrength of a drug without specific permission from the prescribing physician.
n7 n7 7
n n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
REFERENCE: n 7 p. 8 n7
3. The study of drug, including their origin, properties, and interactions with living organisms, is known as
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
a. pharmacogenetics.
b. pharmacology.
c. therapeutics.
d. toxicology.
PRECISE ANSWER:-B n7
Reasoning:->>>Pharmacogenetics is the study of the interrelationship of genetic differences and drug n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
effects. Pharmacology is the study of drug (chemicals), including their origin, properties, and
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
interactionswith living organisms.
n7 7
n n7 n7
Therapeutics is the art of treating illness with drug. Toxicology is the study of toxic substances and
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
theirpharmacologic actions, including antidotes and poison control.
n7 n7 n7 n7 n7 n7 n7 n7
REFERENCE: n 7 p. 3 n7
4. The brand name given to a drug by a particular manufacturer is known as the drug’s
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
a. chemical name. n7
b. generic name. c.official name. d.trade name.
n7 n7 n7 n7 n7
PRECISE ANSWER:-D n7
,Reasoning:->>>The chemical name indicates the drug’s chemical structure. The generic name is assignedby
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 7
n
the United States
n7 n7 n7
, Adopted Name Council and is usually based loosely on the drug’s chemical structure. The official name isthe
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 7
n
name given to the generic name once a drug becomes fully approved for general use and is admitted to
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
the United States Pharmacopeia–National Formulary. The trade name is the brand, or proprietary, name
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
given by a particular manufacturer. For example, the generic drug albuterol is currently marketed by
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
Schering-Plough as Proventil® and by GlaxoSmithKline as Ventolin®.
n7 7
n n7 n7
n7
n7 n7 n7 n7
REFERENCE: n 7 p. 5 n7
5. To find official information about drug (according to the FDA), you need to go to the
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
a. Physician’s Desk Referenceerence (PDR). n7 n7 n7
b. Basic & Clinical Pharmacology. n7 n7 n7
c. United States Pharmacopeia–National Formulary (USP-NF).
n7 n7 n7 n7
d. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. n7 n7 n7 n7 n7 n7 n7
PRECISE ANSWER:-C n7
Reasoning:->>>Because the PDR is prepared by drug manufacturers themselves, it may be lacking in n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
objectivity. Basic & Clinical Pharmacology covers only general pharmacologic principles and drug
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
classes. Goodman & Gilman’s The Pharmacological Basis of Therapeutics covers only general
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
pharmacologicprinciples and drug classes. The USP-NF is a book of standards containing information
n7 7
n n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
about drugs, dietary supplements, and medical devices. The U.S. Food and Drug Administration
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
(FDA)considers this book the official standard for drug marketed in the United States.
n7 7
n n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
REFERENCE: n 7 p. 5 n7
6. Drug may be obtained from which of the following sources?
n7 n7 n7 n7 n7 n7 n7 n7 n7
a. Plants
b. Animals
c. Minerals
d. Plants, animals, and minerals n7 n7 n7
PRECISE ANSWER:-D n7
Reasoning:->>>Drug may be obtained from plants (e.g., digitalis), animals (e.g., insulin), and minerals(e.g.,
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 7
n
magnesium sulfate).
n7 n7
REFERENCE: n 7 p. 5 n7
7. The branch of the U.S. government responsible for the process of approving drug for clinical use is the
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
a. USAN Council. n7
b. FDA.
c. USP-NF.
d. PDR.
PRECISE ANSWER:-B n7
Reasoning:->>>The United States Adopted Name (USAN) Council is responsible for assigning a generic n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
name to a chemical that appears to have therapeutic use. The U.S. Food and Drug Administration
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
(FDA) is responsible for the process of approving drug for clinical use. The process by which a
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
chemical movesfrom the status of a promising potential drug to one fully approved by the FDA for
n7 n7 7
n n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
general clinical use is,on average, long, costly, and complex. Cost estimates vary, but in the 1980s it
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
took an average of 13 to 15 yearsfrom chemical synthesis to marketing approval by the FDA, with a cost
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7
of $350 million in the United States.
n7 n7 n7 n7 n7 n7 n7
The USP-NF is a book
n7 n7 n7 n7
of standards for drugs, dietary supplements, and medical devices. The PDR is a source of druginformation
n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 n7 7
n
prepared by drug manufacturers.
n7 n7 n7 n7
REFERENCE: n 7 p. 4 n7
